Why women choose at-home abortion via teleconsultation in France: drivers of telemedicine abortion during and beyond the COVID-19 pandemic

Objectives In an attempt to understand the demand and main drivers of telemedicine abortion, we analysed the requests that Women on Web (WoW), an online telemedicine abortion service operating worldwide, received from France throughout 2020. Methods We conducted a parallel, convergent, mixed-methods study among 809 consultations received from France at WoW between 1 January and 31 December 2020. We performed a cross-sectional study of data obtained from the WoW consultation survey and a manifest content analysis of anonymised email correspondence of 140 women consulting with the WoW helpdesk from France. Findings We found that women encounter macro-level, individual-level and provider-level constraints while trying to access abortion in France. The preferences and needs over secrecy (n=356, 46.2%), privacy (n=295, 38.3%) and comfort (n=269, 34.9%) are among the most frequent reasons for women from France to choose telemedicine abortion through WoW. The COVID-19 pandemic seems to be an important driver for resorting to telemedicine (n=236, 30.6%). The lockdowns had a significant impact on the number of consultations received at WoW from France, increasing from 60 in March to 128 in April during the first lockdown and from 54 in October to 80 in November during the second lockdown. Conclusions The demand for at-home medical abortion via teleconsultation increased in France during the lockdowns. However, drivers of telemedicine abortion are multidimensional and go beyond the conditions unique to the pandemic.

[1]  P. Lohr,et al.  Effectiveness, safety and acceptability of no‐test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study , 2021, BJOG : an international journal of obstetrics and gynaecology.

[2]  Karen McCabe,et al.  Telemedicine medical abortion at home under 12 weeks’ gestation: a prospective observational cohort study during the COVID-19 pandemic , 2021, BMJ Sexual & Reproductive Health.

[3]  A. Agostini,et al.  COVID-19 impact in abortions’ practice, a regional French evaluation , 2020, Journal of Gynecology Obstetrics and Human Reproduction.

[4]  C. Aiken,et al.  Demand for self-managed online telemedicine abortion in eight European countries during the COVID-19 pandemic: a regression discontinuity analysis , 2020, BMJ Sexual & Reproductive Health.

[5]  Rishita Nandagiri,et al.  COVID-19 and Abortion: Making Structural Violence Visible. , 2020, International perspectives on sexual and reproductive health.

[6]  K. Gemzell‐Danielsson,et al.  Abortion regulation in Europe in the era of COVID-19: a spectrum of policy responses , 2020, BMJ Sexual & Reproductive Health.

[7]  Sophie Günther,et al.  Why women choose abortion through telemedicine outside the formal health sector in Germany: a mixed-methods study , 2020, BMJ Sexual & Reproductive Health.

[8]  C. Aiken,et al.  Demand for Self-Managed Online Telemedicine Abortion in the United States During the Coronavirus Disease 2019 (COVID-19) Pandemic , 2020, Obstetrics and gynecology.

[9]  D. Grossman Telemedicine for medical abortion – time to move towards broad implementation , 2019, BJOG : an international journal of obstetrics and gynaecology.

[10]  Guillaume Beaussonie L'égalité entre les femmes et les hommes , 2019 .

[11]  Lotsa Web Team Nora's Stars - Terms of Use and Privacy Policy , 2017 .

[12]  D. Grossman,et al.  Sixteen Years of Overregulation: Time to Unburden Mifeprex. , 2017, The New England journal of medicine.

[13]  G. Kleiverda,et al.  Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services , 2008, BJOG : an international journal of obstetrics and gynaecology.

[14]  J. Bouyer,et al.  Access to health care for induced abortions: analysis by means of a French national survey. , 2004, European journal of public health.